Skip to content

Author

Peng Li

We have 1 of 5 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Jul 2026

Circular Bivalent Aptamer Chimeras Leveraging LDLR-Mediated Lysosomal Shuttling for Targeted Protein Degradation.

A lysosome-targeting degradation platform based on circular bivalent aptamer chimeras (CBACs), which simultaneously engage the lysosomal shuttle receptor LDLR and target membrane proteins, which demonstrates efficient and selective degradation of two cancer-therapeutically relevant membrane proteins in multiple cancer cells, leading to apoptosis and reduced invasion and migration.

Ningyi Li, Zhen-Zhen Guo, Ruirui Zhang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.